Nathalie Khoury

机构：Denali Therapeutics (United States)

发表论文 64 篇 · 总被引 4680 次 · h-index 22

代表论文

• A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk (2022 · Nature · 被引 843)
• Molecular hallmarks of heterochronic parabiosis at single-cell resolution (2022 · Nature · 被引 157)
• Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia (2022 · Molecular Neurodegeneration · 被引 130)
• Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution (2025 · Nature Communications · 被引 60)
• Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA (2025 · Science · 被引 56)
• Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 13)